The Timing of Corticosteroid Injections after Shoulder Arthroscopy Affects Postoperative Infection Risk

Michelle Elizabeth Kew,Jourdan M. Cancienne,James E. Christensen,Brian C. Werner

DOI: https://doi.org/10.1177/2325967119S00384

IF: 2.6

2019-11-22

Orthopaedic Journal of Sports Medicine

Abstract:To examine the association between the timing of post-operative corticosteroid injections with rates of post-operative infection in arthroscopic shoulder procedures. Private-payer and Medicare national insurance databases were queried for patients who underwent arthroscopic rotator cuff repair, debridement, or subacromial decompression. Patients who underwent corticosteroid injections within 1 month, 2 months, 3 months, or 4 months post-operatively were identified and compared to a matched control group that underwent the same surgeries without a postoperative steroid injection. ICD-9 and CPT codes were used to identify rates of post-operative infection within 90 days after injection for the study groups and controls. Multivariate binomial logistic regression analysis was used to compare groups and adjusted odds ratios (OR) and 95% confidence intervals were calculated with p< 0.05 considered significant. A total of 3,946 patients were identified, including 264 patients who received an injection within 1 month after surgery, 471 within 2 months, 1,037 within, 1,874 within 4 months, and 2,640 matched controls. Compared to controls, patients who underwent a corticosteroid injection within 1 month postoperatively had a significantly higher rate of infection (PP: OR 2.63, p=0.014; MC: OR 11.2, p<0.0001). There were no differences in infection rates at all other time points: (p =0.264 -0.835). This study adds to the evidence suggesting caution when administering injections in the immediate post-operative period following arthroscopic shoulder surgery. Although causality cannot be determined on the basis of this administrative database review, we found a significant association between intra-articular ipsilateral corticosteroid injections administered 1 month post-operatively and an increased rate of post-operative infection, in both a Medicare and private payer patient cohort, when compared to a control patient group. Table 1. Infection Rate Stratified by Post-Operative Injection Timing (Humana) Table 1. Infection Rate Stratified by Post-Operative Injection Timing (Humana) Table 2. Infection Rate Stratified by Post-Operative Injection Timing (Medicare) Table 2. Infection Rate Stratified by Post-Operative Injection Timing (Medicare)

orthopedics,sport sciences